• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - MEYZIEU PRISMAFLEX M150; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - MEYZIEU PRISMAFLEX M150; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 109990
Device Problems Device Operates Differently Than Expected (2913); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Disseminated Intravascular Coagulation (DIC) (1813); Blood Loss (2597)
Event Date 05/04/2018
Event Type  malfunction  
Manufacturer Narrative
Lot number: two of the five sets were from lot number 18a1502, and one set was from each of the following lot numbers: 17g2706, 18a3002 and 17k3004.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that a patient experienced blood loss, disseminated intravascular coagulation (dic), and unresponsiveness during continuous renal replacement therapy (crrt) using five prismaflex m150 sets.Approximately 12 hours after the start of therapy, a blood leak detected alarm occurred.However, there was no blood leak noted, only air in the line.The air chamber of the first set was empty and approximately one or two inches of air was noted below the air bubble detector and above the blood leak detector.The reporter stated that the first prismaflex set was discontinued and 56 ml of blood was returned to the patient.The second prismaflex was discontinued after a ¿return extremely positive¿ alarm, and the blood in the circuit was not returned to the patient.The third prismaflex set was discontinued after a warning ¿air in blood¿ alarm which occurred two seconds after start.The treatment was discontinued without blood restitution.The fourth prismaflex set was discontinued after 22 minutes following six ¿access extremely negative¿ and six ¿return extremely positive¿ alarms.The blood returned to the patient was 26 ml.The patient¿s vascular line (catheter) was found to be clotted likely after replacement of the fourth set and the access had to be ¿de clotted¿ prior to restart of crrt.Due to the clot, treatment was not resumed for ¿several hours.¿ the patient was diagnosed with dic and citrate was provided as anticoagulation using the fifth prismaflex set.Around 15-30 minutes after therapy was begun using the fifth prismaflex set, the patient became unresponsive.The accumulated blood loss was approximately 800 ml.No additional information is available.
 
Manufacturer Narrative
Additional information: a batch review was conducted for all four reported lots, and there were no deviations found related to this reported condition during the manufacture of any of these lots.A photograph of an unspecified sample was received.Visual inspection of the photograph did not identify any abnormalities that could have contributed to the reported condition.The reported condition was not verified through evaluation of the photograph.An actual sample from lot 18a1502 was received for evaluation.Visual inspection of the returned sample did not identify any abnormalities that could have contributed to the reported condition.No leaks or cracks were detected on the three pod membranes and connections.A priming test was performed with the returned sample, and no leaks or air intake were noted.A self-test was then performed by using the set with a prismaflex machine.The machine did not present any alarms during the self-test.The reported condition was not verified for the returned sample of lot 18a1502.The other involved prismaflex m150 sets were not returned for analysis; therefore, a device evaluation could not be performed for the remaining three sets.The involved prismaflex machine was made available for evaluation.The event history log review revealed that the prismaflex control unit alarmed for air in return line and stopped the treatment.According to the review of the logs, the user did not perform the troubleshooting sequence offered by the machine and instead stopped treatment.The prismaflex device has an air detector that continuously monitors the return line for air bubbles.A warning alarm occurs if a bubble is detected.The return line clamp will close and prevent blood and/or air from passing to the patient.Review of the log files also revealed that the machine had presented access extremely negative, return extremely positive, and clotting alarms.The cause of the alarms presented by the machine could not be determined.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX M150
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE - MEYZIEU
meyzieu cedex rhone
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key7576222
MDR Text Key110328333
Report Number8010182-2018-00047
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K080519
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 06/06/2018,07/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number109990
Device Lot NumberSEE H10
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/28/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA06/06/2018
Distributor Facility Aware Date05/09/2018
Event Location Hospital
Date Report to Manufacturer06/06/2018
Date Manufacturer Received06/12/2018
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age61 YR
-
-